Specific inhibitory effect of κ-carrageenan polysaccharide on swine pandemic 2009 H1N1 influenza virus

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Shao, Qiang ^a   Guo, Qiang ^a   Xu, Wen Ping ^a   Li, Zandong ^a   Zhao, Tong Tong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CARRAGEENAN; INFLUENZA VACCINE; MESSENGER RNA; POLYSACCHARIDE; VIRUS PROTEIN; CELL SURFACE RECEPTOR; SIALIC ACID RECEPTOR; VIRUS RECEPTOR;

2009 H1N1 INFLUENZA; A CALIFORNIA 04 2009 H1N1; A CHICKEN SHANDONG LY 2008 H9N2; A PURETO RICO 8 34 H1N1; A SWINE BEIJING 26 2008 H1N1; A SWINE SHANDONG 731 2009 H1N1; A WSN 1933 H1N1; ADSORPTION; ANTIVIRAL ACTIVITY; ARTICLE; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TEST; IMMUNOFLUORESCENCE TEST; INFLUENZA VIRUS A H1N1; MDCK CELL LINE; NONHUMAN; PANDEMIC INFLUENZA; PROTEIN EXPRESSION; SWINE INFLUENZA VIRUS; TISSUE CULTURE; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING; ANIMAL; DOG; DRUG EFFECTS; GENE EXPRESSION REGULATION; HUMAN; INFLUENZA A VIRUS (H1N1); METABOLISM; MICROBIAL SENSITIVITY TEST; PANDEMIC; PHYSIOLOGY; VIRUS ATTACHMENT; VIRUS ENTRY;

ORTHOMYXOVIRIDAE; RHODOPHYTA; SUIDAE;

ANIMALS; ANTIVIRAL AGENTS; CARRAGEENAN; DOGS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; MICROBIAL SENSITIVITY TESTS; PANDEMICS; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84929377758     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126577     Document Type: Article

References (29)

1. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939. doi: 10.1038/nature08157 PMID: 19525932
2. Malik Peiris J, Poon LL, Guan Y (2009) Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. Journal of Clinical Virology 45: 169-173. doi: 10.1016/j.jcv.2009.06.006 PMID: 19540800
3. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng P-Y, et al. (2012) Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. The Lancet infectious diseases 12: 687-695. doi: 10.1016/S1473-3099(12)70121-4 PMID: 22738893
4. Control CfD, Prevention (2009) H1N1 Flu. Plastic surgical nursing: official journal of the American Society of Plastic and Reconstructive Surgical Nurses 29: 271. doi: 10.1097/PSN.0b013e3181c63dcd PMID: 20029312
5. Sun Y, Xu Q, Shen Y, Liu L, Wei K, Sun H, et al. (2014) Naturally occurring mutations in the PA gene are key contributors to increased virulence of pandemic H1N1/09 influenza virus in mice. Journal of virology 88: 4600-4604. doi: 10.1128/JVI.03158-13 PMID: 24522908
6. Talarico LB, Damonte EB (2007) Interference in dengue virus adsorption and uncoating by carrageenans. Virology 363: 473-485. PMID: 17337028
7. Carlucci M, Scolaro L, Noseda M, Cerezo A, Damonte E (2004) Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice. Antiviral research 64: 137-141. PMID: 15498610
8. Grassauer A, Weinmuellner R, Meier C, Pretsch A, Prieschl-Grassauer E, Unger H (2008) Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Virology journal 5: 107. doi: 10.1186/1743-422X-5-107 PMID: 18817582
9. Buck CB, Thompson CD, Roberts JN, Müller M, Lowy DR, Schiller JT (2006) Carrageenan is a potent inhibitor of papillomavirus infection. PLoS pathogens 2: e69. PMID: 16839203
10. Yamada T, Ogamo A, Saito T, Uchiyama H, Nakagawa Y (2000) Preparation of O-acylated low-molecular-weight carrageenans with potent anti-HIV activity and low anticoagulant effect. Carbohydrate Polymers 41: 115-120.
11. Yamada T, Ogamo A, Saito T, Watanabe J, Uchiyama H, Nakagawa Y (1997) Preparation and anti-HIV activity of low-molecular-weight carrageenans and their sulfated derivatives. Carbohydrate Polymers 32: 51-55.
12. Girond S, Crance J, Van Cuyck-Gandre H, Renaudet J, Deloince R (1991) Antiviral activity of carrageenan on hepatitis A virus replication in cell culture. Research in virology 142: 261-270. PMID: 1665574
13. Chiu Y-H, Chan Y-L, Tsai L-W, Li T-L, Wu C-J (2012) Prevention of human enterovirus 71 infection by kappa carrageenan. Antiviral research 95: 128-134. doi: 10.1016/j.antiviral.2012.05.009 PMID: 22643729
14. Wang W, Zhang P, Hao C, Zhang X-E, Cui Z-Q, Guan H-S (2011) In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus. Antiviral research 92: 237-246. doi: 10.1016/j.antiviral.2011.08.010 PMID: 21867732
15. Leibbrandt A, Meier C, König-Schuster M, Weinmüllner R, Kalthoff D, Pflugfelder B, et al. (2010) Iotacarrageenan is a potent inhibitor of influenza A virus infection. PLoS ONE 5: e14320. doi: 10.1371/journal.pone.0014320 PMID: 21179403
16. Damonte EB, Matulewicz MC, Cerezo AS (2004) Sulfated seaweed polysaccharides as antiviral agents. Current medicinal chemistry 11: 2399-2419. PMID: 15379705
17. Pujol C, Scolaro L, Ciancia M, Matulewicz M, Cerezo A, Damonte E (2006) Antiviral Activity of a Carrageenan from EM EMTYPE. Planta medica 72: 121-125. PMID: 16491446
18. Harden EA, Falshaw R, Carnachan SM, Kern ER, Prichard MN (2009) Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus. Antiviral research 83: 282-289. doi: 10.1016/j.antiviral.2009.06.007 PMID: 19576248
19. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology 27: 493-497.
20. Livak KJ, Schmittgen TD (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2ΔΔCT Method. methods 25: 402-408. PMID: 11846609
21. Chen C-J, Chen G-W, Wang C-H, Huang C-H, Wang Y-C, Shih S-R (2010) Differential localization and function of PB1-F2 derived from different strains of influenza A virus. Journal of virology 84: 10051-10062. doi: 10.1128/JVI.00592-10 PMID: 20660199
22. Potier M, Mameli L, Belisle M, Dallaire L, Melancon S (1979) Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrate. Analytical biochemistry 94: 287-296. PMID: 464297
23. Kim M, Yim JH, Kim S-Y, Kim HS, Lee WG, Kim SJ, et al. (2012) In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03. Antiviral research 93: 253-259. doi: 10.1016/j.antiviral.2011.12.006 PMID: 22197247
24. Deshpande KL, Fried VA, Ando M, Webster RG (1987) Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc Natl Acad Sci U S A 84: 36-40. PMID: 3467357
25. Gunther I, Glatthaar B, Doller G, Garten W (1993) A H1 hemagglutinin of a human influenza A virus with a carbohydrate-modulated receptor binding site and an unusual cleavage site. Virus Res 27: 147-160. PMID: 8460527
26. Wang W, Wang S-X, Guan H-S (2012) The antiviral activities and mechanisms of marine polysaccharides: an overview. Marine drugs 10: 2795-2816. doi: 10.3390/md10122795 PMID: 23235364
27. Bae S-Y, Yim JH, Lee HK, Pyo S (2006) Activation of murine peritoneal macrophages by sulfated exopolysaccharide from marine microalga Gyrodinium impudicum (strain KG03): Involvement of the NF-κB and JNK pathway. International immunopharmacology 6: 473-484. PMID: 16428083
28. Yim JH, Son E, Pyo S, Lee HK (2005) Novel sulfated polysaccharide derived from red-tide microalga Gyrodinium impudicum strain KG03 with immunostimulating activity in vivo. Marine Biotechnology 7: 331-338. PMID: 15976942
29. Zhou G-f, Li S-f, Wang C-h (2010) Immunomodulating effects of sulfated κ-carrageenan. Marine Sciences 8: 011.